Yahoo Finance 10 Must-See Portraits from Sunday Night's 2022 Streamy Awards
Stars and fans came out in Los Angeles Sunday night to celebrate the best of the Internet — and we're sharing the glam pics
Stars and fans came out in Los Angeles Sunday night to celebrate the best of the Internet — and we're sharing the glam pics
Q1 2024 NerdWallet Inc Earnings Call
Newey has never worked with seven-time world champion Hamilton but the design guru’s likely exit from Red Bull paves the way for a dream partnership in Italy – if Newey wants one final challenge
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation
Chinese foreign minister warns of ‘downward spiral’ of rivalry, confrontation and conflict
Fiona Beal, of Moore Street, Northampton, was arrested in March 2022 after police discovered the body
Q1 2024 SS&C Technologies Holdings Inc Earnings Call
Former Hollywood producer found guilty in 2020 of raping and assaulting two women
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation
Q1 2024 Capital One Financial Corp Earnings Call
Microsoft and Google jumped on earnings late after the market rally attempt showed resilience Thursday amid Meta's sell-off.
The allies of Republican presidential candidate Donald Trump are drafting proposals that would attempt to erode the Federal Reserve's independence if he wins, the Wall Street Journal reported on Thursday, citing people familiar with the matter. The group argues that Trump should be consulted on rate decisions and would have the authority to remove Jerome Powell as Fed Chair before his term ends in 2026, the report added. The Journal said it could not determine if the former president was aware of or signed off on the effort, but some people close to the discussions believe the work has received his blessing.
‘I know, I can’t believe it either,’ the comedian wrote
NASHVILLE, Tenn., April 26, 2024--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.
Pharmacy Automation Systems Market Pharmacy Automation Systems Market Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Pharmacy Automation Systems Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.The global pharmacy automation systems market is expected to reach US$ 11.12 billion in 2022 to US$ 22.63 billion by 2030; the market is est
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Boston, MA, April 26, 2024 (GLOBE NEWSWIRE) -- MiniLuxe Holding Corp. (TSXV: MNLX) ("MiniLuxe" or the "Company") is pleased to announce that it has completed a "top up" closing of a non-brokered convertible debenture unit offering, yielding gross proceeds of approximately US$500,000 (the "Offering"). The Offering mirrors the terms of the Company's previously completed debenture financing tranches w
JOHNS CREEK, Ga., April 26, 2024 (GLOBE NEWSWIRE) -- Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, today reported first quarter 2024 financial results. Diluted earnings per share for the quarter were $3.38 compared to $2.85 in the first quarter of 2023. Highlights from the first quarter operating results were as follows: First Quarter 2024 Compared to First Quarter 2023 Results Reve
VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- Ceylon Graphite Corp. (“Ceylon” or the “Company”) (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) announces that it intends issue 548,999 common shares (collectively, the “Interest Shares”) in satisfaction of interest (the “Interest”) due on secured convertible debenture units of the Company (the “Debentures”). The Company previously announced the issuance of the Debentures in an aggregate principal amount of C$365,000 in its news release date
TORONTO, April 26, 2024--Adya, Inc. ("Adya" or the "Company"), (TSX-V:ADYA; OTCQB: ADYIF) announces the successful completion of the sale of its indirectly owned subsidiary, Ellora Telecom Philippines Inc., to an arm’s length third party. This strategic move, finalized on May 2, 2023, was executed pursuant to a share purchase agreement for a total consideration of $420,000 in cash (the "Disposition").
NEW YORK, April 26, 2024--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) ("The Cannabist Company" or the "Company"), one of the largest and most experienced cultivators, manufacturers, and retailers of cannabis products in the U.S., announced today its latest expansion with Airo Brands, an industry-leading, multi-state cannabis company focused on proprietary, cutting-edge vapor delivery platforms and flavorful, high quality oils, into Virginia and Pennsylvania.
PASADENA, Calif., April 26, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company’s proprietary Targeted RNAi Molecule (TRiMTM) platform. Each webinar in the Summer Series will focus on a specific therapeutic area and will feature presentations by Arrowhead team members about the company’s clinical candidates and external key